|
Title
|
|
|
|
CEO research orientation, organizational context, and innovation in the pharmaceutical industry
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| This study develops and tests a comprehensive framework that explains what, when, and how CEO characteristics influence firms' innovation outcomes in R&D-intensive industries. Empirical evidence from 109 CEOs from 87 U.S.-based pharmaceutical firms over the period 2001-2013 reveals that research-oriented CEOs - those with ability and motivation for science and technology - increase their firms' innovation outcomes. The results indicate that the CEO-innovation relationship strongly depends on the extent of CEOs' managerial discretion, which is shaped by the organizational context. We contribute to a more comprehensive understanding of the role of CEOs in firms ' innovation performance differentials. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
R & D management. - Oxford
| |
|
Publication
|
|
|
|
Hoboken
:
Wiley
,
2020
| |
|
ISSN
|
|
|
|
0033-6807
| |
|
DOI
|
|
|
|
10.1111/RADM.12394
| |
|
Volume/pages
|
|
|
|
50
:2
, p. 239-254
| |
|
ISI
|
|
|
|
000490242400001
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|